Copyright: ©Author(s) 2026.
Artif Intell Gastrointest Endosc. Sep 8, 2026; 7(2): 118493
Published online Sep 8, 2026. doi: 10.37126/aige.118493
Published online Sep 8, 2026. doi: 10.37126/aige.118493
Table 1 Key artificial intelligence platforms for inflammatory bowel disease and non-inflammatory bowel disease neoplasia detection
| AI platform | Indication | Training dataset | IBD specific training | Sensitivity (%) | Specificity (%) | Population validated |
| EndoBRAIN-Plus[13] | Colorectal CADe | Approximately 68000 endocytoscopic images | No | 98.7 | 77.1 | Japan, Europe |
| GI genius[14] | Polyp detection | MMX trial videos (150 videos, 338 polyps) | No | 82 | 98 | United States |
| Vinsard IBD-CADe[11] | IBD neoplasia | Approximately 1700 IBD dysplasia images | Yes | 95.1 | 98.8 | United States |
| EfficientNet-B3[9] | IBD neoplasia | 862 IBDN images + data augmentation | Yes | 72.5 | 82.9 | Japan |
- Citation: Bhandari R, Gartlan J, Oppong P, Chhabra P. Artificial intelligence for inflammatory bowel disease dysplasia detection: Current evidence and future directions. Artif Intell Gastrointest Endosc 2026; 7(2): 118493
- URL: https://www.wjgnet.com/2689-7164/full/v7/i2/118493.htm
- DOI: https://dx.doi.org/10.37126/aige.118493